Cambridge Trust’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-80
Closed -$16.8K 666
2023
Q4
$16.8K Buy
+80
New +$17.1K ﹤0.01% 527
2023
Q3
Sell
-50
Closed -$9.27K 718
2023
Q2
$9.27K Hold
50
﹤0.01% 603
2023
Q1
$9.58K Hold
50
﹤0.01% 636
2022
Q4
$8K Sell
50
-11
-18% -$1.91K ﹤0.01% 658
2022
Q3
$11K Buy
61
+11
+22% +$2.17K ﹤0.01% 630
2022
Q2
$10K Hold
50
﹤0.01% 682
2022
Q1
$12K Buy
+50
New +$11.7K ﹤0.01% 726

Other funds holding CME

Cambridge Trust's CME Position: Q1 2024 in Review

Cambridge Trust sold out of CME Group (CME) in Q1 2024, closing a stake of 80 shares — an estimated $16.8K sold.

Cambridge Trust first reported a position in CME in Q1 2022 and held it in 7 quarters. The position peaked at $16.8K in Q4 2023. 1,376 funds tracked by Wall St. Rank hold CME as of Q1 2024.

  • Cambridge Trust reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
  • Cambridge Trust sold 80 CME Group shares in Q1 2024, an estimated $16.8K.
  • Cambridge Trust first reported a position in CME Group in Q1 2022 and held it in 7 quarters.
  • Cambridge Trust's CME Group position peaked at $16.8K in Q4 2023.
  • 1,376 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.